Companies/EU/NSIS-B

NOVOZYMES A/S

Income flow

Annual
NSIS-B ANNUAL Income StatementPeriod 2026-06-30Source ANNUAL
Net salesEUR 2B+100% Y/YRevenueEUR 2B+100% Y/YGross profitEUR 1B+98% Y/YCost of revenueEUR 979MOperating profitEUR 520M+95% Y/YOperating expensesEUR 737MNet profitEUR 371M+86% Y/YTaxEUR 108MR&D & otherEUR 615MSG&AEUR 122M

As-filed revenue segments and annual P&L (gross, opex, tax, net). Layout inspired by SankeyArt finance diagrams.

Capital & dividends

YieldTrailing twelve-month dividends as a percent of the current share price (income yield).1.47%5y avgAverage dividend yield over the past five years — a smoother view than the latest print.1.41%Trailing DPSCash dividends paid per share over the last twelve months (dividend per share, trailing).0.885PayoutShare of earnings paid out as dividends. Higher means more income returned; lower leaves more for reinvestment.64.0%Shares outTotal shares currently outstanding (issued and not retired).412.5MFloatShares available to trade — outstanding minus closely held (insiders, strategic holders).347.6M
Dividend calendar
Ex-dividend
2026-08-25
Last cash
2.35 · 2026-08-25
Stock splits
  1. 5:12011-11-28